Benjamin Haynor
Stock Analyst at Lake Street
(0.95)
# 3,828
Out of 4,974 analysts
11
Total ratings
20%
Success rate
-1.5%
Average return
Main Sectors:
Stocks Rated by Benjamin Haynor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELMD Electromed | Assumes: Buy | $36 | $24.47 | +47.12% | 1 | Aug 27, 2025 | |
| PROF Profound Medical | Maintains: Buy | $17 → $11 | $4.12 | +166.99% | 1 | Apr 23, 2025 | |
| VSAT Viasat | Maintains: Buy | $31 → $19 | $29.65 | -35.92% | 5 | Sep 20, 2024 | |
| CGNT Cognyte Software | Downgrades: Hold | n/a | $9.01 | - | 2 | Mar 13, 2018 | |
| DRIO DarioHealth | Initiates: Buy | $1,400 | $9.60 | +14,483.33% | 1 | Aug 29, 2017 | |
| SRDX Surmodics | Initiates: Buy | $44 | $32.34 | +34.53% | 1 | Jun 27, 2017 |
Electromed
Aug 27, 2025
Assumes: Buy
Price Target: $36
Current: $24.47
Upside: +47.12%
Profound Medical
Apr 23, 2025
Maintains: Buy
Price Target: $17 → $11
Current: $4.12
Upside: +166.99%
Viasat
Sep 20, 2024
Maintains: Buy
Price Target: $31 → $19
Current: $29.65
Upside: -35.92%
Cognyte Software
Mar 13, 2018
Downgrades: Hold
Price Target: n/a
Current: $9.01
Upside: -
DarioHealth
Aug 29, 2017
Initiates: Buy
Price Target: $1,400
Current: $9.60
Upside: +14,483.33%
Surmodics
Jun 27, 2017
Initiates: Buy
Price Target: $44
Current: $32.34
Upside: +34.53%